tiprankstipranks
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market
2162
Keymed Biosciences, Inc.
RESEARCH TOOLSreports
Want to see HK:2162 full AI Analyst Report?

Keymed Biosciences, Inc. (2162) Financial Statements

1 Followers

Keymed Biosciences, Inc. Financial Overview

Keymed Biosciences, Inc.'s market cap is currently HK$17.22B. The company's EPS TTM is HK$-1.76; its P/E ratio is -8.22; Keymed Biosciences, Inc. is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is HK$6.58. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 697.77M¥ 428.12M¥ 354.10M¥ 100.06M¥ 110.27M
Gross Profit¥ 516.51M¥ 415.92M¥ 317.22M¥ 97.48M¥ 93.07M
Operating Income¥ -584.85M¥ -618.10M¥ -434.80M¥ -543.81M¥ -3.88B
EBITDA¥ -489.36M¥ -574.46M¥ -269.77M¥ -259.25M¥ -3.86B
Net Income¥ -509.11M¥ -515.24M¥ -359.36M¥ -308.12M¥ -3.90B
Balance Sheet
Cash & Short-Term Investments¥ 1.96B¥ 2.16B¥ 2.72B¥ 3.18B¥ 3.52B
Total Assets¥ 4.22B¥ 3.77B¥ 3.88B¥ 3.93B¥ 3.93B
Total Debt¥ 788.88M¥ 753.24M¥ 418.71M¥ 121.97M¥ 39.26M
Net Debt¥ 245.71M¥ 334.82M¥ -432.32M¥ -482.10M¥ -1.48B
Total Liabilities¥ 1.44B¥ 1.29B¥ 896.11M¥ 593.10M¥ 289.07M
Stockholders' Equity¥ 2.78B¥ 2.47B¥ 2.99B¥ 3.34B¥ 3.65B
Cash Flow
Free Cash Flow¥ -1.05B¥ -1.00B¥ -686.23M¥ -681.48M¥ -387.50M
Operating Cash Flow¥ -712.41M¥ -789.63M¥ -303.62M¥ -401.93M¥ -214.64M
Investing Cash Flow¥ 39.08M¥ 67.71M¥ 468.20M¥ -645.59M¥ -2.04B
Financing Cash Flow¥ 788.72M¥ 283.90M¥ 72.13M¥ -8.06M¥ 3.64B
Currency in CNY

Keymed Biosciences, Inc. Earnings and Revenue History

Income Statement >

Keymed Biosciences, Inc. Debt to Assets

Balance Sheet >

Keymed Biosciences, Inc. Cash Flow

Cash Flow >

Keymed Biosciences, Inc. Forecast EPS vs Actual EPS

Earnings >